Home / Inspections / 1191619

FDA Inspection 1191619 — ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. — FEI 2111358

The FDA completed an inspection of ANI Pharmaceuticals, Inc. on November 18, 2022 in Baudette, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 18, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Baudette, MN (United States)

Facility

Other inspections at this facility

  • 1250465 (VAI Fri Dec 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1089435 (NAI Fri Apr 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983493 (NAI Thu Jul 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 852937 (NAI Fri Sep 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 762035 (VAI Fri Jan 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources